Doctors look at the levels of each in your blood to monitor your multiple myeloma. In your pee, this marker is called the Bence-Jones protein. If the ratio of the two types of free light chains is ...

Stage 2 multiple myeloma is an intermediate phase. This means the blood test markers and cancer genetic markers fall between ...

In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...

Markers include M-protein blood levels of ... damage to internal organs that could indicate progression to active multiple myeloma. Because there's a lack of symptoms, immediate treatment isn ...

The company's flagship assay uses whole-genome sequencing to identify patients with high-risk multiple myeloma and determine which patients won't respond to therapies.

providing local laboratories and/or routine hospital settings with an excellent level of detection of multiple myeloma markers, which could be described as pan-genomic technology on a human scale.

Agency drug reviewers had questioned patient risk criteria and the efficacy endpoint used in a key trial supporting J&J's ...

providing local laboratories and/or routine hospital settings with an excellent level of detection of multiple myeloma markers, which could be described as pan-genomic technology on a human scale.

It allows for the visualization of all rearrangements and numerical anomalies of the samples in a single layer, providing local laboratories and/or routine hospital settings with an excellent level of ...